🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the effects of rosuvastatin compared...
Status
Completed
Location
Research site
Start Date
2002-11
Trial ID
NCT00800800
Treatments Being Tested
The purpose of this study is to measure the effect of ticagrelor on the pha...
Status
Completed
Location
Research Site
Start Date
2024-08-05
Trial ID
NCT06554821
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
This study will assess the safety, tolerability, pharmacokinetics (PK), and...
Status
Completed
Location
Research Site
Start Date
2022-05-18
Trial ID
NCT05384262
Our hypothesis is that treating relapsed or refractory multiple myeloma wit...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2014-02
Trial ID
NCT02030483
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
A 24-month prospective, open-label, randomized, multicenter, multinational,...
Status
Active Not Recruiting
Location
Univ. Lille, CHU Lille
Start Date
2023-11-28
Trial ID
NCT05575167
Treatments Being Tested
The primary purpose of this study is to assess the effect of repeated doses...
Status
Completed
Location
Worldwide Clinical Trials (WCT) Early Phase Services
Start Date
2015-05-12
Trial ID
NCT03699774
Treatments Being Tested